Abvc Biopharma (ABVC) Short-Term Debt issuances (2012 - 2026)

Abvc Biopharma (ABVC) has 9 years of Short-Term Debt issuances data on file, last reported at $661650.0 in Q1 2026.

• Quarterly Short-Term Debt issuances rose 2162.05% year-over-year to $661650.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $751301.0 (up 2468.55% YoY) and the FY2025 annual result came in at $120400.0, up 301.33% from the prior year.
• Short-Term Debt issuances climbed to $661650.0 in Q1 2026, from $30119.0 in the prior quarter.
• In the past five years, Short-Term Debt issuances ranged from a high of $1.0 million in Q1 2023 to a low of $29250.0 in Q1 2025.
• A 4-year average of $258650.1 and a median of $30094.0 in 2025 frame the typical range for Short-Term Debt issuances.
• Annual changes were most pronounced in 2024 — Short-Term Debt issuances slumped 97.0% — and 2026, when it soared 2162.05%.
• Tracing ABVC's Short-Term Debt issuances over 4 years: stood at $1.0 million in 2023, then tumbled by 97.0% to $30000.0 in 2024, then climbed by 0.4% to $30119.0 in 2025, then jumped by 2096.79% to $661650.0 in 2026.
• The last three Short-Term Debt issuances figures came in at $661650.0 (Q1 2026), $30119.0 (Q4 2025), and $30094.0 (Q3 2025), per Business Quant data.